FGEN Competitors & Alternatives
Compare FibroGen Inc with similar stocks in the same industry
Biotechnology
FGEN
Main Stock$9.71
Tradestie Score
43
Market Cap
$48.63M
Revenue Growth
7.7%
Analyst Upside
+342.8%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.87
|
$133.50M | - | 31 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.67
|
$117.07M | - | 30 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$4.81
|
$114.01M | - | 57 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$30.62
|
$110.20M | - | 41 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.55
|
$97.42M | - | 50 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.22
|
$84.52M | - | 40 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.07
|
$67.94M | - | 52 | Compare |
|
TPIC
TPIC
|
- | - | - | - | Compare |
|
AFMD
AFMD
|
- | - | - | - | Compare |
|
MEIP
MEIP
|
- | - | - | 49 | Compare |
More FGEN Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry